Literature DB >> 12766837

Outcomes analysis of delayed antibiotic treatment for hospital-acquired Staphylococcus aureus bacteremia.

Thomas P Lodise1, Peggy S McKinnon, Linda Swiderski, Michael J Rybak.   

Abstract

The objective of this study was to determine the effect of delayed therapy on morbidity and mortality associated with nosocomial Staphylococcus aureus bacteremia. The study included all episodes of S. aureus bacteremia that developed >2 days after hospital admission during 1999 to 2001. Classification and regression tree analysis (CART) was used to select the mortality breakpoint between early and delayed treatment. During the 25-month study period, 167 patients met the inclusion criteria. The breakpoint between delayed and early treatment derived using CART was 44.75 hours. On multivariate analysis, delayed treatment was found to be an independent predictor of infection-related mortality (odds ratio, 3.8; 95% confidence interval, 1.3-11.0; P=.01) and was associated with a longer hospital stay than was early treatment (20.2 days versus 14.3 days; P=.05). These findings support the notion that delay of therapy has deleterious effects on clinical outcomes, and efforts should be made to ensure that appropriate therapy is initiated promptly.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12766837     DOI: 10.1086/375057

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  150 in total

1.  Clinical impact of a real-time PCR assay for rapid identification of staphylococcal bacteremia.

Authors:  Abigail M Frye; Catherine A Baker; D Leif Rustvold; Kim A Heath; Jessica Hunt; James E Leggett; Margret Oethinger
Journal:  J Clin Microbiol       Date:  2011-11-09       Impact factor: 5.948

2.  Suitability of initial antibiotic therapy for the treatment of bloodstream infections and the potential role of antibiotic management teams in improving it.

Authors:  S Diamantis; C Rioux; C Bonnal; É Farfour; E Papy; A Andremont; P Yeni; É Bouvet; J-C Lucet
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-12-02       Impact factor: 3.267

3.  The importance of a judicious and early empiric choice of antimicrobial for methicillin-resistant Staphylococcus aureus bacteraemia.

Authors:  N Shime; T Kosaka; N Fujita
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2010-08-14       Impact factor: 3.267

4.  USA600 (ST45) methicillin-resistant Staphylococcus aureus bloodstream infections in urban Detroit.

Authors:  Carol L Moore; Paola Osaki-Kiyan; Marybeth Perri; Susan Donabedian; Nadia Z Haque; Anne Chen; Marcus J Zervos
Journal:  J Clin Microbiol       Date:  2010-03-24       Impact factor: 5.948

5.  Rapid identification of bacteria from positive blood culture bottles by use of matrix-assisted laser desorption-ionization time of flight mass spectrometry fingerprinting.

Authors:  Martin Christner; Holger Rohde; Manuel Wolters; Ingo Sobottka; Karl Wegscheider; Martin Aepfelbacher
Journal:  J Clin Microbiol       Date:  2010-03-17       Impact factor: 5.948

6.  Predictors of Adverse Outcomes in Children With Staphylococcus aureus Bacteremia.

Authors:  Ganesh Kumarachandran; Jennifer Kristie Johnson; Debbie-Ann Shirley; Eileen Graffunder; Emily L Heil
Journal:  J Pediatr Pharmacol Ther       Date:  2017 May-Jun

7.  MRSA bacteraemia in patients on arrival in hospital: a cohort study in Oxfordshire 1997-2003.

Authors:  David H Wyllie; Tim E A Peto; Derrick Crook
Journal:  BMJ       Date:  2005-09-09

Review 8.  Antibiotic pharmacokinetic and pharmacodynamic considerations in critical illness.

Authors:  Rina Mehrotra; Raffaele De Gaudio; Mark Palazzo
Journal:  Intensive Care Med       Date:  2004-11-05       Impact factor: 17.440

Review 9.  Antimicrobial stewardship programs in health care systems.

Authors:  Conan MacDougall; Ron E Polk
Journal:  Clin Microbiol Rev       Date:  2005-10       Impact factor: 26.132

10.  The effective use of a summary table and decision tree methodology to analyze very large healthcare datasets.

Authors:  David Sibbritt; Robert Gibberd
Journal:  Health Care Manag Sci       Date:  2004-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.